These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9561978)

  • 1. Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy.
    Chamberlain MC; Kormanik P
    Arch Neurol; 1998 Apr; 55(4):506-12. PubMed ID: 9561978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy.
    Chamberlain MC; Kormanik PR
    J Neurooncol; 1997 Oct; 35(1):55-64. PubMed ID: 9266441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal metastases due to melanoma.
    Chamberlain M; Kormanik P
    Int J Oncol; 1996 Sep; 9(3):505-10. PubMed ID: 21541542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphomatous meningitis in immunocompetent patients.
    Chamberlain M; Kormanik P
    Oncol Rep; 1997; 4(6):1311-8. PubMed ID: 21590244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined-modality treatment of leptomeningeal gliomatosis.
    Chamberlain MC
    Neurosurgery; 2003 Feb; 52(2):324-29; discussion 330. PubMed ID: 12535360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik PA; Barba D
    J Neurosurg; 1997 Nov; 87(5):694-9. PubMed ID: 9347977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-related central nervous system lymphomas.
    Chamberlain MC; Kormanik PA
    J Neurooncol; 1999 Jul; 43(3):269-76. PubMed ID: 10563433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
    Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
    Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
    Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
    Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment.
    Boogerd W; Hart AA; van der Sande JJ; Engelsman E
    Cancer; 1991 Mar; 67(6):1685-95. PubMed ID: 2001559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.
    Chamberlain MC; Kormanik P; Glantz M
    Oncol Rep; 1998; 5(2):521-5. PubMed ID: 9468593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis.
    Chamberlain MC; Dirr L
    J Clin Oncol; 1993 Oct; 11(10):1978-84. PubMed ID: 7692000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric leptomeningeal metastases: outcome following combined therapy.
    Chamberlain MC
    J Child Neurol; 1997 Jan; 12(1):53-9. PubMed ID: 9010796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases.
    Chamberlain MC; Kormanik PA
    Neurology; 1996 Jun; 46(6):1674-7. PubMed ID: 8649568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer.
    Gwak HS; Joo J; Kim S; Yoo H; Shin SH; Han JY; Kim HT; Lee JS; Lee SH
    J Thorac Oncol; 2013 May; 8(5):599-605. PubMed ID: 23422833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidermal growth factor tyrosine kinase inhibitors used in the treatment of NSCLC patients with leptomeningeal metastasis].
    Xu Y; Zhong W; Zhao J; Chen MJ; Zhang L; Li LY; Wang MZ
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):920-924. PubMed ID: 27998469
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.
    Park JH; Kim YJ; Lee JO; Lee KW; Kim JH; Bang SM; Chung JH; Kim JS; Lee JS
    Lung Cancer; 2012 Jun; 76(3):387-92. PubMed ID: 22186628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of leptomeningeal metastases in pediatrics.
    Chamberlain MC
    J Child Neurol; 1995 May; 10(3):191-9. PubMed ID: 7642887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.